APN News

  • Monday, December, 2019| Today's Market | Current Time: 10:57:51
  • India likely to have 80 million diabetics by 2030: WHO

    The World Health Organisation (WHO) has warned that the number of diabetics in India might leap to 80 million from the present 32 million by the year 2030. The International Diabetes Federation (IDF) has, however, reported that the number of 50.8 million diabetics in the country now would rise to 87 million in the next […]

    WIN Consortium Announces the 3rd Annual WIN Symposium: Gateways to Efficacy of Cancer Diagnostics and Therapeutics

    France :The Worldwide Innovative Networking (WIN) Consortium invites you to attend the 3rd WIN Annual Symposium, which this year is dedicated to a very challenging topic: gateways to increasing the efficacy of cancer diagnostics and therapeutics.  The 2011 symposium, to be held on 6th to 8th of July at the Palais des Congrès, Paris, will […]

    De Montfort University: Diabetes Expert Develops Artificial Pancreas

    United Kingdom : A researcher from the UK has developed an artificial pancreas which could revolutionise the treatment of diabetes and put a stop to daily injections. Professor Joan Taylor from De Montfort University in Leicester, UK, is developing a device which would be implanted into the body between the lowest rib and the hip […]

    Dr. Jaseela Anvar of Punarnava Ayurveda Hospital bags the AHMA Best Clinical Case Presentation Award

    Kochi: The best clinical case presentation award instrumented by Ayurveda Hospital Management Association (AHMA) this year has been bagged by Dr. Jaseela Anvar, Medical Director of Punarnava Ayurveda Hospital. The award, consists of AHMA-Nangelil ever rolling trophy and a cash price, was presented to Dr. Jaseela by Smt. PK Sreemathy Teacher, Minister of Health, Kerala […]

    Welch Allyn Partners with Pelstar

    New York : Welch Allyn, a leading global provider of medical diagnostic equipment, announced it has partnered with Pelstar, LLC, maker of Health o meter Professional Scales, to co-brand the Health o meter line of professional medical weight scales for distribution in markets outside the United States and Canada. The agreement will allow Welch Allyn […]

    Huber Receives Approval to Produce Active Pharmaceutical Ingredients

    United States:  Huber Engineered Materials, a division of the J.M. Huber Corporation, has received approval for its Health & Nutrition business to begin producing active pharmaceutical ingredients (APIs), such as calcium carbonate granulation for use in the manufacturing of antacids and other pharma applications. The license granted by California’s Department of Public Health – Food […]

    univadis and The Lancet Announce New Partnership

    United States : MSD (known as Merck in the United States and Canada) is pleased to announce an exciting and exclusive new partnership between univadis® – (MSD’s medical education and unbiased health information website) and The Lancet – (one of the world’s leading independent general medical journals). Through a unique global medical literature service called Just […]

    BGS Global Hospitals Offers Treatment for Stroke without Surgery

    Treatment for stroke without surgery is now possible at BGS Global Hospitals, one of the leading tertiary care multi super speciality hospitals in Bangalore, India. Advanced Neurosciences Institute at BGS Global Hospitals has added another advanced service and innovative procedure to its facilities in the treatment of stroke. The hospital will soon be equipped with […]

    IBA Introduces Proteus ONE, a Smaller, More Cost-Effective Proton Therapy System

    United States :A smaller, more efficient and cost-effective Proton Therapy system from IBA Particle Therapy will soon be available for cancer treatment centers. This single-room system is roughly one-third the size of the current gantry configuration and offers a smaller cyclotron, a shorter proton-beam route from the cyclotron to the treatment room, and a more […]

    Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Shows Rapid Viral Response without Use of Pegylated Interferon

    United States : Boehringer Ingelheim announced results from a Phase Ib study, SOUND-C1, that showed the combination of two oral hepatitis C virus (HCV) compounds, the protease inhibitor BI 201335 and the polymerase inhibitor BI 207127, with ribavirin reduced viral load to the lower limit of quantifiable levels in HCV treatment-naïve patients. The regimen did […]